263 related articles for article (PubMed ID: 38437543)
1. Electrostatic adsorption of polyanions onto lipid nanoparticles controls uptake, trafficking, and transfection of RNA and DNA therapies.
Nabar N; Dacoba TG; Covarrubias G; Romero-Cruz D; Hammond PT
Proc Natl Acad Sci U S A; 2024 Mar; 121(11):e2307809121. PubMed ID: 38437543
[TBL] [Abstract][Full Text] [Related]
2. Chemistry of Lipid Nanoparticles for RNA Delivery.
Eygeris Y; Gupta M; Kim J; Sahay G
Acc Chem Res; 2022 Jan; 55(1):2-12. PubMed ID: 34850635
[TBL] [Abstract][Full Text] [Related]
3. Lipid nanoparticle formulations for optimal RNA-based topical delivery to murine airways.
Tam A; Kulkarni J; An K; Li L; Dorscheid DR; Singhera GK; Bernatchez P; Reid G; Chan K; Witzigmann D; Cullis PR; Sin DD; Lim CJ
Eur J Pharm Sci; 2022 Sep; 176():106234. PubMed ID: 35688311
[TBL] [Abstract][Full Text] [Related]
4. Helper lipid structure influences protein adsorption and delivery of lipid nanoparticles to spleen and liver.
Zhang R; El-Mayta R; Murdoch TJ; Warzecha CC; Billingsley MM; Shepherd SJ; Gong N; Wang L; Wilson JM; Lee D; Mitchell MJ
Biomater Sci; 2021 Feb; 9(4):1449-1463. PubMed ID: 33404020
[TBL] [Abstract][Full Text] [Related]
5. Development of Polymer-Lipid Hybrid Nanoparticles for Large-Sized Plasmid DNA Transfection.
Maeki M; Uno S; Sugiura K; Sato Y; Fujioka Y; Ishida A; Ohba Y; Harashima H; Tokeshi M
ACS Appl Mater Interfaces; 2024 Jan; 16(2):2110-2119. PubMed ID: 38141015
[TBL] [Abstract][Full Text] [Related]
6. Optimization of DOTAP/chol Cationic Lipid Nanoparticles for mRNA, pDNA, and Oligonucleotide Delivery.
Sun M; Dang UJ; Yuan Y; Psaras AM; Osipitan O; Brooks TA; Lu F; Di Pasqua AJ
AAPS PharmSciTech; 2022 May; 23(5):135. PubMed ID: 35534697
[TBL] [Abstract][Full Text] [Related]
7. Intracellular trafficking kinetics of nucleic acid escape from lipid nanoparticles via fluorescence imaging.
M Bailey-Hytholt C; Ulinski G; Dugas J; Haines M; Lazebnik M; Piepenhagen P; E Zarraga I; Bandekar A
Curr Pharm Biotechnol; 2023 Apr; ():. PubMed ID: 37016519
[TBL] [Abstract][Full Text] [Related]
8. Bile acid-containing lipid nanoparticles enhance extrahepatic mRNA delivery.
Patel SK; Billingsley MM; Mukalel AJ; Thatte AS; Hamilton AG; Gong N; El-Mayta R; Safford HC; Merolle M; Mitchell MJ
Theranostics; 2024; 14(1):1-16. PubMed ID: 38164140
[TBL] [Abstract][Full Text] [Related]
9. Lipid nanoparticles containing labile PEG-lipids transfect primary human skin cells more efficiently in the presence of apoE.
Gregersen CH; Mearraoui R; Søgaard PP; Clergeaud G; Petersson K; Urquhart AJ; Simonsen JB
Eur J Pharm Biopharm; 2024 Apr; 197():114219. PubMed ID: 38368913
[TBL] [Abstract][Full Text] [Related]
10. Electrophoretic Microfluidic Characterization of mRNA- and pDNA-Loaded Lipid Nanoparticles.
De Peña AC; Zimmer D; Gutterman-Johns E; Chen NM; Tripathi A; Bailey-Hytholt CM
ACS Appl Mater Interfaces; 2024 May; 16(21):26984-26997. PubMed ID: 38753459
[TBL] [Abstract][Full Text] [Related]
11. Flash nanoprecipitation assisted self-assembly of ionizable lipid nanoparticles for nucleic acid delivery.
Misra B; Hughes KA; Pentz WH; Samart P; Geldenhuys WJ; Bobbala S
Nanoscale; 2024 Apr; 16(14):6939-6948. PubMed ID: 38511623
[TBL] [Abstract][Full Text] [Related]
12. Lung-selective mRNA delivery of synthetic lipid nanoparticles for the treatment of pulmonary lymphangioleiomyomatosis.
Qiu M; Tang Y; Chen J; Muriph R; Ye Z; Huang C; Evans J; Henske EP; Xu Q
Proc Natl Acad Sci U S A; 2022 Feb; 119(8):. PubMed ID: 35173043
[TBL] [Abstract][Full Text] [Related]
13. Highly efficient CD4+ T cell targeting and genetic recombination using engineered CD4+ cell-homing mRNA-LNPs.
Tombácz I; Laczkó D; Shahnawaz H; Muramatsu H; Natesan A; Yadegari A; Papp TE; Alameh MG; Shuvaev V; Mui BL; Tam YK; Muzykantov V; Pardi N; Weissman D; Parhiz H
Mol Ther; 2021 Nov; 29(11):3293-3304. PubMed ID: 34091054
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of a DoE based approach for comprehensive modelling of the effect of lipid nanoparticle composition on nucleic acid delivery.
Qin Y; Walters AA; Rouatbi N; Wang JT; Abdel-Bar HM; Al-Jamal KT
Biomaterials; 2023 Aug; 299():122158. PubMed ID: 37243988
[TBL] [Abstract][Full Text] [Related]
15. Incorporation of poly(γ-glutamic acid) in lipid nanoparticles for enhanced mRNA delivery efficiency in vitro and in vivo.
Zhang H; Gao X; Sun Q; Dong X; Zhu Z; Yang C
Acta Biomater; 2024 Mar; 177():361-376. PubMed ID: 38342193
[TBL] [Abstract][Full Text] [Related]
16. Next-generation materials for RNA-lipid nanoparticles: lyophilization and targeted transfection.
Wang T; Sung TC; Yu T; Lin HY; Chen YH; Zhu ZW; Gong J; Pan J; Higuchi A
J Mater Chem B; 2023 Jun; 11(23):5083-5093. PubMed ID: 37221913
[TBL] [Abstract][Full Text] [Related]
17.
Algarni A; Pilkington EH; Suys EJA; Al-Wassiti H; Pouton CW; Truong NP
Biomater Sci; 2022 May; 10(11):2940-2952. PubMed ID: 35475455
[TBL] [Abstract][Full Text] [Related]
18. Lipid Nanoparticle Formulations for Enhanced Co-delivery of siRNA and mRNA.
Ball RL; Hajj KA; Vizelman J; Bajaj P; Whitehead KA
Nano Lett; 2018 Jun; 18(6):3814-3822. PubMed ID: 29694050
[TBL] [Abstract][Full Text] [Related]
19. Development of Lipidoid Nanoparticles for siRNA Delivery to Neural Cells.
Khare P; Dave KM; Kamte YS; Manoharan MA; O'Donnell LA; Manickam DS
AAPS J; 2021 Dec; 24(1):8. PubMed ID: 34873640
[TBL] [Abstract][Full Text] [Related]
20. Modulating the Nature of Ionizable Lipids and Number of Layers in Hyaluronan-Decorated Lipid Nanoparticles for In Vitro Delivery of RNAi.
Passos Gibson V; Tahiri H; Gilbert C; Yang C; Phan QT; Banquy X; Hardy P
Pharmaceutics; 2024 Apr; 16(4):. PubMed ID: 38675224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]